Vaidya Sane Ayurved Laboratories Limited · NSE:MADHAVBAUG
Vaidya Sane Ayurved Laboratories — H1 FY26 Earnings Presentation
43 slides from Vaidya Sane Ayurved Laboratories's earnings presentation, Nov 6, 2025
Slide 1: NSE Regulation 30 disclosure letter
Date: 06th November 2025 To, Listing Compliance Department, National Stock Exchange of India Limited, Exchange Plaza, Bandra Kurla Complex, Bandra East, Mumbai-400051 NSE Symbol: Madhavbaug Sub: Disclosure under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations,
Slide 2: Investor Presentation
Vaidya Sane Ayurved Laboratories Limited Investor Presentation
Slide 3: Disclaimer
Disclaimer This presentation has been prepared by Vaidya Sane Ayurved Laboratories Limited (the “Company”) solely for information purposes and does not constitute any offer, recommendation or invitation to purchase or subscribe for any securities, and shall not form the basis or be relied on in conn
Slide 4: Table of contents
Table of contents 01 02 03 04 05 3
Slide 5: Company Overview
@ Company Overview —
Slide 6: About Us
About Us Among leading chains of Cardiac care clinics & State of Art Fully Equipped Hospitals Hospitals ▪ Madhavbaug Hospital Khopoli (NABH Accredited) ▪ Unique medical service institution – focus on ▪ Madhavbaug Hospital Nagpur Traditional Medicine ▪ Madhavbaug Vizag Hospital ▪ Strives to reduce In
Slide 7: Company structure
Company structure F-Health Accelerators Pvt. Ltd. Easy Ayurveda Pvt. Ltd. Aaharshashtra Foodz Pvt. Ltd. 01 (80% Holding) 02 (15% Holding) 03 (20% Holding) ▪ Shareholding Agreement with Dr. ▪ Incorporated a Company with Ms. Pooja ▪ Focus on start-ups that work in the Janardhana V Hebbar Patil where C
Slide 8: Madhavbaug's 360 Degree Ecosystem
Madhavbaug’s 360 Degree Ecosystem Patients’ vitals monitored on continuous basis through CMS Holistic Treatment and MIB (Madhavbaug Standardized Medicine – Methodology leading to Information Backbone) Pulse prescribed and dispensed objective results Application from clinics Researched diets, tested
Slide 9: Journey so far
Journey so far ▪ Completion of first production batch of madhavshakti Atta at New Factory, ▪ Listing of shares on NSE-Emerge of UV Ayurgen Pharma Private ▪ Khopoli Hospital empanelment with SBI Limited General Insurance ▪ Participated in Ayush Medical Value ▪ NABH of Madhavbaug Khopoli Hospital Trav
Slide 10: Strong & experienced management
Strong & experienced management Dr. Rohit Sane – Chairman & Managing Director ▪ MBBS (Medicine and Surgery) and fellowship in Cardiac Rehabilitation ▪ More than 20 years of experience in health care consulting ▪ Pioneer in conceptualizing and promoting Ayurveda in healing of chronic heart diseases -
Slide 11: Strong & experienced management
Strong & experienced management ▪ BAMS, MD (Samhita, Siddhant), PGDEMS and Certified Black belt in Six Sigma Dr. Gurudatta Amin ▪ Affiliated with Madhavbaug since 2007, worked on various levels in medical operations, and Designated as CMO since 2012 Chief Medical Officer ▪ Designed Medical Strategie
Slide 12: Key Strengths
Key Strengths Strong Research based Treatments & Therapies with papers published and accepted internationally Unique combination of modern healing 01 methods and ancient natural practices 02 Experienced Leadership with able & well- trained team led by Dr. Rohit Madhav Sane Effective, Non- Invasive &
Slide 13: Business Overview
\ Business Overview
Slide 14: Madhavbaug's Unique Model
Madhavbaug’s Unique Model Business Clinic Revenue Model Model FY25 Revenue: Rs. 145.55 Cr Hospitals Clinics Services Products ▪ *Revenue : Rs. 23.20 Cr ▪ *Revenue : Rs. 145.55 Cr ▪ *Revenue : Rs. 86.68 Cr ▪ *Revenue : Rs. 58.86 Cr Hospitals, Products, 13.75% 40.44% Clinics, Services, 86.25% 59.56% *
Slide 15: Holistic Treatment Programs
Holistic Treatment Programs Treatment Programs Secondary Prevention & Rehabilitation Programs: ▪ Heart Failure Reversal Therapy (HFRT) ▪ Plaque Stabilization Therapy (PST) ▪ Ischemia Reversal Programme (IRP) ▪ Diabetic Complication Management (DHCM) ▪ Endo protector ▪ Hypertensive Complication Manag
Slide 16: With innovative reversal therapies
…With innovative reversal therapies… Heart Disease Diabetes Blood Pressure Obesity Reversal Reversal Management Management ▪ Cardioprotective Therapy ▪ Comprehensive Diabetic Care ▪ Blood Pressure Management ▪ Obesity Management ▪ Ischemic Reversal Program Program Program Program ▪ CAD Management ▪
Slide 17: Pan India Network as on 30th Sept 2025
With Pan India Network as on 30th Sept.2025 States No. of Clinics Delhi NCR 6 Uttar Pradesh 11 Madhya Pradesh 12 Gujarat 23 Goa 1 Maharashtra 245 Karnataka 20 Telangana 2 Madhavbaug Hospital Khopoli, Madhavbaug Hospital Kondhali Total 320 Madhavbaug Vizag Hospital Madhavbaug Vadodara Hospital Madhav
Slide 18: State of Art Hospitals – Khopoli, Kondhali & Vizag
State of Art Hospitals – Khopoli, Kondhali & Vizag Khopoli Hospital (Revenue in Rs. Cr) Kondhali Hospital (Revenue in Rs. Cr) ▪ Madhavbaug Hospital Khopoli – 1st Hospital in 2006 9.38 3.29 3.21 ▪ Madhavbaug Hospital Kondhali, Nagpur – 2nd Hospital in 2012 2.53 8.30 ▪ Madhavbaug Vizag Hospital – Vish
Slide 19: Multidisciplinary Cardiac Care Clinics
Multidisciplinary Cardiac Care Clinics 18
Slide 20: Multidisciplinary Cardiac Care Clinics
Multidisciplinary Cardiac Care Clinics No. of Clinics (Ownershipwise) Average Revenue per Clinic (Rs. in Lacs) Clinic Enterprise Revenue (In Rs. Lacs) No. of Patient - Total Footfall 353 49.19 333 8,02,697 302 9,025 8,564 8,668 277 266 249 6,542 6,344 7,80,462 196 43.21 6,259 5,887 178 42.23 4,909 7
Slide 21: Empanelment with Insurance Companies & TPA's
Empanelment with Insurance Companies & TPA’s Insurance Companies Third Party Administrators (TPA) More than 30 Insurance companies empaneled with above Third Party Administrators (TPA) each 20
Slide 22: Madhavbaug Power Map
Madhavbaug Power Map ▪ Medical analytics service built for Madhavbaug Doctors to help them reverse Chronic cardiac disease of their patients effectively - ▪ Union Minister for Road Transport and Highways Nitin Gadkari inaugurated Madhavbaug's Power MAP on 15th January 2022 ▪ Critical Care ▪ Diet Man
Slide 23: MIB Pulse App
Mib Pulse App - Enable Healthcare reach to lowest strata ▪ It’s a free app which anyone can use from anywhere in case of Medical assistance ▪ App gives you full past history of your health MIB Pulse App (+100K Downloads) ▪ Medical Assistance ✓ Connected Medical Assistance of Doctors to give patients
Slide 24: Research based Disease reversal Diet Kits
Research based Disease reversal Diet Kits 23
Slide 25: Industry Overview
@ Industry Overview
Slide 26: India's Non-Communicable Disease (NCD)
India’s Non – Communicable Disease (NCD) Challenges 66% of all death in India caused by Non – Communicable diseases ▪ Roughly 77 million Diabetes patients in India – Second Highest in the World India estimated to have 44 million Diabetes ▪ Every 2 minutes, someone in India dies from diabetes or its
Slide 27: Higher Stress increasing Diseased population
Higher Stress increasing Diseased population Middle Class Population ( In million) 800.0 400.0 153.0 Working Age Population of India 2010 2020 2030 (in million) 665.0 Share of Non-communicable diseases 495.0 574.0 – Causes of death, India, 2000-25 463.0 397.0 66.0% 68.0% 70.0% 71.0% 56.0% 62.0% 46.0
Slide 28: Re-emergence of Traditional Medical Care
Re-emergence of Traditional Medical Care Market size and services offered Notable trends ▪ Indian Ayurvedic Industry expected to reach US$ 9 ▪ Traditional medical sector developing Traditional Knowledge billion by 2022 - Ayurveda medicines - > 90% plant Digital Library to prevent companies from clai
Slide 29: Financial Highlights
@ Financial Highlights
Slide 30: Management Comments
Management Comments “During the first half of FY26, Vaidya Sane Ayurved Laboratories Ltd (Madhavbaug) continued to deliver consistent growth and operational improvement across its core verticals of Ayurvedic healthcare and wellness products. Company recorded a consolidated revenue of ₹49.94 crore in
Slide 31: Recent Developments
Recent Developments ▪ Increase in authorized capital from INR 15,00,00,000/- (Rupees Fifteen Crores only) divided into 1,50,00,000 (One Crore Fifty Lakhs) Equity Shares of INR 10/- (Rupees Ten only) each to INR 20,00,00,000/- (Rupees Twenty Crores only) divided into 2,00,00,000 (Two Crores) Equity S
Slide 32: Madhavbaug Welcomes Sonu Sood as Official Brand Ambassador
Madhavbaug Welcomes Sonu Sood as Official Brand Ambassador 31
Slide 33: Madhavbaug Expands with First Hospital in Gujarat
Madhavbaug Expands Holistic Healthcare with First Hospital in Gujarat ▪ Opening of its first hospital in Gujarat and fourth hospital overall. The newly launched 35-bed facility, situated in Ankodiya village, Vadodara, spans 8 acres and is dedicated to providing advanced holistic treatments for cardi
Slide 34: Consolidated Half Yearly Financial Highlights
Consolidated Half Yearly Financial Highlights Enterprise Collection (Rs. Cr) Revenue (Rs. Cr) 81.27 75.63 69.92 51.10 49.94 48.23 48.05 41.80 8.30 8.04 9.38 2.53 0.26 0.00 3.29 0.78 0.00 3.21 0.93 0.22 H1 FY25 H2 FY25 H1 FY26 VSAL Clinics & OPD and Mini Clinics Khopoli Hospital Kondhali Hospital Viz
Slide 35: Consolidated Financial Highlights – Half Yearly
Consolidated Financial Highlights – Half Yearly Rs. Crore H1 FY26 H1 FY25 Y-o-Y (%) H2 FY25 Income from Operations 49.94 41.80 48.05 Other Operating Income 0.00 0.00 0.00 ▪ Revenue from operations for H1 FY26 is Total Income 49.94 41.80 19.48% 48.05 49.94 Crs as against Rs. 41.80 Crs in H1 Raw Mater
Slide 36: Consolidated Financial Highlights – Yearly
Consolidated Financial Highlights – Yearly Rs. Crore FY25 FY24 Y-o-Y (%) Income from Operations 89.85 99.33 ▪ Revenue from operations for FY25 is Other Operating Income 0.00 0.00 89.85 Crs as against Rs. 99.33 Crs in FY24, Total Income 89.85 99.33 (9.55%) YoY decrease of 9.55% - reduction in total R
Slide 37: Annual Financial Highlights
Annual Financial Highlights Enterprise Collection (Rs. Cr) Revenue (Rs. Cr) VSAL Clinics & OPD and Mini Clinics Khopoli Hospital Kondhali Hospital Vizag Hospital 99.17 99.33 89.85 157.95 149.00 145.55 74.71 114.70 52.27 19.00 23.00 26.42 15.34 5.00 0.00 7.00 0.00 7.09 0.08 6.82 1.04 FY22 FY23 FY24 F
Slide 38: Balance Sheet as on 30th September 2025
Balance Sheet as on 30th September 2025 As on 30th As on 31st As on 30th As on 31st Rs. Crore Rs. Crore Sept’ 25 Mar’ 25 Sept’ 25 Mar’ 25 Shareholder’s Funds 67.73 62.55 Non-current assets 52.98 52.57 Share capital 10.52 10.52 Property, Plant & Equipment 20.86 21.45 Other Equity 57.22 52.03 Tangible
Slide 39: Key Balance Sheet Ratios
Key Balance Sheet Ratios RoE(%) RoA(%) 8.80% 9.3% 11.94% 11.41% 6.94% 9.67% 4.02% 3.60% 1.52% 2.87% FY21 FY22* FY23 FY24 FY25 FY21 FY22* FY23 FY24 FY25 RoCE(%) 16.95% 19.4% 17.76% 15.44% 5.63% FY21 FY22* FY23 FY24 FY25 * IPO in FY22 to raise Rs. 20.23 crs RoE = Net Profit/Net Worth | RoA = Net Profi
Slide 40: Way Ahead
@ Way Ahead
Slide 41: Way Ahead
Way Ahead Scalable and Standardized Clinic Design ▪ Clinic-based health care delivery model along with tele-medicine - low capex requirement and easy accessibility Strengthening and Expanding Clinic and Hospital Network ▪ Strategic locations in Maharashtra; expand Clinic Network in Madhya Pradesh, U
Slide 42: Madhavbaug's Mission 2028
Madhavbaug’s Mission 2028 “By 2028, Over 5 Crore People in India will be directly under Madhavbaug’s Care” .. 01 02 03 04 Save My Heart – App Madhavbaug Associate Clinics & Hospitals OPD Purported for preventation 1000 Associate Doctors Expansion of Khopoli Existing network of 50 of heart disease as
Slide 43: Thank You
Thank You For further information, please contact: Ms. Sapna Vaishnav Vaidya Sane Ayurved Laboratories Ltd Tel: +91 7400192238 Email: cs@Madhavbaug.com Website: www.madhavbaug.org Mr. Amit Sharma / Mr. Rupesh Rege AdfactorsPR Pvt. Ltd. Tel: +91 98677 26686 /+91 9594918891 Email: amit.sharma@adfactor
Vaidya Sane Ayurved Laboratories — H1 FY26 Earnings Presentation on 6ix